Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.26 USD | +0.78% | -0.78% | +234.55% |
May. 17 | Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform | MT |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.87B |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -171M | EV / Sales 2024 * | - |
Net cash position 2024 * | 895M | Net cash position 2025 * | 749M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-55.7
x | P/E ratio 2025 * |
-40.2
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.1% |
Latest transcript on Viking Therapeutics, Inc.
1 day | +0.78% | ||
1 week | -0.78% | ||
1 month | -18.54% | ||
3 months | -26.94% | ||
6 months | +378.55% | ||
Current year | +234.55% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Lian
FOU | Founder | 58 | 12-09-23 |
Gregory Zante
DFI | Director of Finance/CFO | 53 | 16-01-04 |
Marianne Mancini
COO | Chief Operating Officer | 59 | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Foehr
BRD | Director/Board Member | 51 | 14-04-30 |
J. Singleton
BRD | Director/Board Member | 71 | 14-04-30 |
Charles Rowland
BRD | Director/Board Member | 65 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 2 M€ | -.--% | ||
0.06% | 7 M€ | -.--% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 62.26 | +0.78% | 2,219,793 |
24-05-30 | 61.78 | -3.18% | 2,365,023 |
24-05-29 | 63.81 | -2.37% | 1,643,187 |
24-05-28 | 65.36 | +4.16% | 2,288,667 |
24-05-24 | 62.75 | +1.92% | 2,124,779 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+234.55% | 6.87B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- VKTX Stock